Novartis CEO Joseph Jimenez discusses how funding cuts to health care will affect the pharmaceutical industry.

  • untitled
In this ongoing interview series, FORTUNE senior editor-at-large Geoff Colvin examines the biggest challenges in business through conversations with top executives at the heart of those issues.
@geoffcolvin